Bio Green Med Solution, Inc. (BGMS) intrinsic value & 10-year financials
Bio Green Med Solution, Inc. (BGMS) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 1.3% a year to $747.0K, with an average return on invested capital of -6.9%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.91
- Market cap
- $2.0M
- Revenue (FY2025)
- $747.0K
- Revenue growth (10-yr CAGR)
- -1.3%
- ROIC (10-yr avg)
- -6.9%
- Free cash flow (FY2025)
- —
BGMS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $747.0K | -$3.0M | -$6.45 | — | -1128.1% | 854.7% |
| FY2024 | $43.0K | -$11.2M | -$2.09 | — | -27916.3% | 279.0% |
| FY2023 | $420.0K | -$22.6M | -$4.46 | -$16.1M | -6060.2% | 822.4% |
| FY2022 | $0 | -$21.2M | -$0.32 | -$20.8M | — | 2266.7% |
| FY2021 | $0 | -$18.9M | -$0.36 | -$18.6M | — | -2318.3% |
| FY2020 | $0 | -$8.4M | -$0.57 | -$8.0M | — | -970.0% |
| FY2019 | — | -$7.8M | — | -$9.5M | — | -828.2% |
| FY2018 | $150.0K | -$7.3M | — | -$6.7M | -6365.3% | -43.6% |
| FY2017 | $0 | -$7.5M | — | -$7.5M | — | -46.5% |
| FY2016 | $843.0K | -$11.8M | — | -$10.1M | -1678.5% | -84.9% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Bio Green Med Solution, Inc. is facing top-line stagnation, with revenue contracting over the decade.
Bio Green Med Solution, Inc. has historically struggled to out-earn its cost of capital, averaging just -17.4% ROIC.
Bio Green Med Solution, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Bio Green Med Solution, Inc. is modeled at -1.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-32.50 per share.